Literature DB >> 16731527

Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to platelet-endothelial cell adhesion molecule 1 to limit mast cell activation.

Christian M Udell1, Lionel A Samayawardhena, Yuko Kawakami, Toshiaki Kawakami, Andrew W B Craig.   

Abstract

Mast cells express the high affinity IgE receptor FcepsilonRI, which upon aggregation by multivalent antigens elicits signals that cause rapid changes within the mast cell and in the surrounding tissue. We previously showed that FcepsilonRI aggregation caused a rapid increase in phosphorylation of both Fer and Fps/Fes kinases in bone marrow-derived mast cells. In this study, we report that FcepsilonRI aggregation leads to increased Fer/Fps kinase activities and that Fer phosphorylation downstream of FcepsilonRI is independent of Syk, Fyn, and Gab2 but requires Lyn. Activated Fer/Fps readily phosphorylate the C terminus of platelet-endothelial cell adhesion molecule 1 (Pecam-1) on immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and a non-ITIM residue (Tyr(700)) in vitro and in transfected cells. Mast cells devoid of Fer/Fps kinase activities display a reduction in FcepsilonRI aggregation-induced tyrosine phosphorylation of Pecam-1, with no defects in recruitment of Shp1/Shp2 phosphatases observed. Lyn-deficient mast cells display a dramatic reduction in Pecam-1 phosphorylation at Tyr(685) and a complete loss of Shp2 recruitment, suggesting a role as an initiator kinase for Pecam-1. Consistent with previous studies of Pecam-1-deficient mast cells, we observe an exaggerated degranulation response in mast cells lacking Fer/Fps kinases at low antigen dosages. Thus, Lyn and Fer/Fps kinases cooperate to phosphorylate Pecam-1 and activate Shp1/Shp2 phosphatases that function in part to limit mast cell activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731527     DOI: 10.1074/jbc.M604252200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

2.  CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells.

Authors:  Damiana Álvarez-Errico; Irene Oliver-Vila; Erola Ainsua-Enrich; Alasdair M Gilfillan; César Picado; Joan Sayós; Margarita Martín
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

3.  Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Authors:  Benjamin E Tourdot; Michelle K Brenner; Kathleen C Keough; Trudy Holyst; Peter J Newman; Debra K Newman
Journal:  Biochemistry       Date:  2013-04-03       Impact factor: 3.162

4.  Small interfering RNA screen for phosphatases involved in IgE-mediated mast cell degranulation.

Authors:  Juan Zhang; Mary Mendoza; Michel F Guiraldelli; Emilia Alina Barbu; Reuben P Siraganian
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

5.  Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation.

Authors:  Zhangyin Ming; Yu Hu; Jizhou Xiang; Peter Polewski; Peter J Newman; Debra K Newman
Journal:  Blood       Date:  2011-02-04       Impact factor: 22.113

6.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

7.  Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation.

Authors:  Cathy Paddock; Betsy L Lytle; Francis C Peterson; Trudy Holyst; Peter J Newman; Brian F Volkman; Debra K Newman
Journal:  Blood       Date:  2011-04-04       Impact factor: 22.113

8.  Fer kinase limits neutrophil chemotaxis toward end target chemoattractants.

Authors:  Maitham Khajah; Graciela Andonegui; Ronald Chan; Andrew W Craig; Peter A Greer; Donna-Marie McCafferty
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

9.  Quantitative time-resolved phosphoproteomic analysis of mast cell signaling.

Authors:  Lulu Cao; Kebing Yu; Cindy Banh; Vinh Nguyen; Anna Ritz; Benjamin J Raphael; Yuko Kawakami; Toshiaki Kawakami; Arthur R Salomon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

10.  Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.

Authors:  Hui Guan; Zhichao Zhou; Gary E Gallick; Shu-Fang Jia; Jaime Morales; Anil K Sood; Seth J Corey; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.